The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Pulmonary Embolism

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Pulmonary Embolism


Psychiatry related information on Pulmonary Embolism

  • The krypton procedure is preferred in pulmonary embolism suspects because it requires far less patient cooperation than the xenon and aerosol methods and the lung images disclose regional ventilatory impairment quickly and accurately [6].

High impact information on Pulmonary Embolism


Chemical compound and disease context of Pulmonary Embolism


Biological context of Pulmonary Embolism


Anatomical context of Pulmonary Embolism


Gene context of Pulmonary Embolism


Analytical, diagnostic and therapeutic context of Pulmonary Embolism


  1. Heparin to prevent pulmonary embolism and venous thrombosis. Loo, L.K. N. Engl. J. Med. (1988) [Pubmed]
  2. Sickle-cell trait, thalassemia, G-6-PD deficiency and puerperal pulmonary embolism. Jewett, J.F. N. Engl. J. Med. (1976) [Pubmed]
  3. Thrombosis and embolism in long-term central venous access for parenteral nutrition. Dollery, C.M., Sullivan, I.D., Bauraind, O., Bull, C., Milla, P.J. Lancet (1994) [Pubmed]
  4. Effectiveness of low-dose heparin in prevention of myocardial reinfarction. Neri Serneri, G.G., Rovelli, F., Gensini, G.F., Pirelli, S., Carnovali, M., Fortini, A. Lancet (1987) [Pubmed]
  5. Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group. Gärdlund, B. Lancet (1996) [Pubmed]
  6. Inhalation lung imaging with radioactive aerosols and gases. Taplin, G.V., Chopra, S.K. Progress in nuclear medicine. (1978) [Pubmed]
  7. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. Decousus, H., Leizorovicz, A., Parent, F., Page, Y., Tardy, B., Girard, P., Laporte, S., Faivre, R., Charbonnier, B., Barral, F.G., Huet, Y., Simonneau, G. N. Engl. J. Med. (1998) [Pubmed]
  8. Pulmonary embolism in a homocystinuric patient during treatment with dipyridamole and acetylsalicylic acid. Schulman, J.D., Agarwal, B., Mudd, S.H., Shulman, N.R. N. Engl. J. Med. (1978) [Pubmed]
  9. A prospective study of risk factors for pulmonary embolism in women. Goldhaber, S.Z., Grodstein, F., Stampfer, M.J., Manson, J.E., Colditz, G.A., Speizer, F.E., Willett, W.C., Hennekens, C.H. JAMA (1997) [Pubmed]
  10. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. Moser, K.M., Fedullo, P.F., LitteJohn, J.K., Crawford, R. JAMA (1994) [Pubmed]
  11. A prospective investigation of pulmonary embolism in women and men. Quinn, D.A., Thompson, B.T., Terrin, M.L., Thrall, J.H., Athanasoulis, C.A., McKusick, K.A., Stein, P.D., Hales, C.A. JAMA (1992) [Pubmed]
  12. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. Simonneau, G., Sors, H., Charbonnier, B., Page, Y., Laaban, J.P., Azarian, R., Laurent, M., Hirsch, J.L., Ferrari, E., Bosson, J.L., Mottier, D., Beau, B. N. Engl. J. Med. (1997) [Pubmed]
  13. Pulmonary embolism in a transsexual man taking diethylstilbestrol. Lehrman, K.L. JAMA (1976) [Pubmed]
  14. Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Levine, M., Hirsh, J., Gent, M., Arnold, A., Warr, D., Falanga, A., Samosh, M., Bramwell, V., Pritchard, K.I., Stewart, D. Lancet (1994) [Pubmed]
  15. Arterial to end-tidal CO2 gradient as an indicator of silent pulmonary embolism. Taniguchi, S., Irita, K., Sakaguchi, Y., Takahashi, S. Lancet (1996) [Pubmed]
  16. Pulmonary vascular effects of hydralazine in a canine preparation of pulmonary thromboembolism. Ducas, J., Girling, L., Schick, U., Prewitt, R.M. Circulation (1986) [Pubmed]
  17. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity. Nossel, H.L., Ti, M., Kaplan, K.L., Spanondis, K., Soland, T., Butler, V.P. J. Clin. Invest. (1976) [Pubmed]
  18. Plasminogen activator inhibitor-1 suppresses endogenous fibrinolysis in a canine model of pulmonary embolism. Reilly, C.F., Fujita, T., Hutzelmann, J.E., Mayer, E.J., Shebuski, R.J. Circulation (1991) [Pubmed]
  19. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism. Prandoni, P., Carnovali, M., Marchiori, A. Arch. Intern. Med. (2004) [Pubmed]
  20. Hemodynamic management in pulmonary embolism and acute hypoxemic respiratory failure. Prewitt, R.M. Crit. Care Med. (1990) [Pubmed]
  21. Inhibition of prostaglandin synthesis during polystyrene microsphere-induced pulmonary embolism in the rat. Jones, A.E., Watts, J.A., Debelak, J.P., Thornton, L.R., Younger, J.G., Kline, J.A. Am. J. Physiol. Lung Cell Mol. Physiol. (2003) [Pubmed]
  22. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Luu, M., Stevenson, W.G., Stevenson, L.W., Baron, K., Walden, J. Circulation (1989) [Pubmed]
  23. Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up. Meneveau, N., Schiele, F., Metz, D., Valette, B., Attali, P., Vuillemenot, A., Grollier, G., Elaerts, J., Mossard, J.M., Viel, J.F., Bassand, J.P. J. Am. Coll. Cardiol. (1998) [Pubmed]
  24. Bronchoalveolar lavage alterations in pulmonary embolism. Nakos, G., Kitsiouli, E.I., Lekka, M.E. Am. J. Respir. Crit. Care Med. (1998) [Pubmed]
  25. Superior vena caval placement of a Kimray-Greenfield filter. Pais, S.O., De Orchis, D.F., Mirvis, S.E. Radiology. (1987) [Pubmed]
  26. Diffusing capacity is not measurably affected by routine lung perfusion scanning. Morris, T.A., Thompson, B.T., Quinn, D.A., McKusick, K.A., Callahan, R., Hales, C.A. J. Nucl. Med. (1988) [Pubmed]
  27. Homozygous cystathionine beta-synthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis. Kluijtmans, L.A., Boers, G.H., Verbruggen, B., Trijbels, F.J., Novakova, I.R., Blom, H.J. Blood (1998) [Pubmed]
  28. Protection against thrombosis in mice lacking PAR3. Weiss, E.J., Hamilton, J.R., Lease, K.E., Coughlin, S.R. Blood (2002) [Pubmed]
  29. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. Dalla-Volta, S., Palla, A., Santolicandro, A., Giuntini, C., Pengo, V., Visioli, O., Zonzin, P., Zanuttini, D., Barbaresi, F., Agnelli, G. J. Am. Coll. Cardiol. (1992) [Pubmed]
  30. Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism. Minamikawa, K., Wada, H., Wakita, Y., Ohiwa, M., Tanigawa, M., Deguchi, K., Hiraoka, N., Huzioka, H., Nishioka, J., Hayashi, T. Thromb. Haemost. (1994) [Pubmed]
  31. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Goldhaber, S.Z., Haire, W.D., Feldstein, M.L., Miller, M., Toltzis, R., Smith, J.L., Taveira da Silva, A.M., Come, P.C., Lee, R.T., Parker, J.A. Lancet (1993) [Pubmed]
  32. Prevention of Fatal Postoperative pulmonary embolism by low doses of heparin. Reappraisal of results of international multicentre trial. Kakkar, V.V., Corrigan, T.P., Fossard, D.P., Sutherland, I., Thirwell, J. Lancet (1977) [Pubmed]
  33. Chemokines accumulate in the lungs of rats with severe pulmonary embolism induced by polystyrene microspheres. Zagorski, J., Debelak, J., Gellar, M., Watts, J.A., Kline, J.A. J. Immunol. (2003) [Pubmed]
  34. Inferior vena cava filters. Indications, safety, effectiveness. Becker, D.M., Philbrick, J.T., Selby, J.B. Arch. Intern. Med. (1992) [Pubmed]
  35. Safety of thrombolytic therapy in elderly patients with massive pulmonary embolism: a comparison with nonelderly patients. Meneveau, N., Bassand, J.P., Schiele, F., Bouras, Y., Anguenot, T., Bernard, Y., Schultz, R. J. Am. Coll. Cardiol. (1993) [Pubmed]
WikiGenes - Universities